Functional study of autonomic neuropathy in primary (AL) amyloidosis

Fabrizio Gemmi, Anna Miliani, Franco Bergesio, Maurizio Salvadori, Giampaolo Merlini

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In order to evaluate autonomic function in primary amyloidosis (AL), five non invasive tests (Valsalva ratio, heart rate variation during deep breathing, 30/15 ratio, blood pressure response to standing and blood pressure response to sustained handgrip) were performed in 16 patients with positive fat tissue aspirates (FTA) for amyloid (11 females, 5 males, aged 48-85 years). Three of 16 were asymptomatic and without signs of organ involvement. Ten normal subjects and 10 patients with monoclonal gammopathy of undetermined significance (MGUS) of similar age were studied as controls. Abnormal autonomic function was found in 15 of the 16 patients with AL amyloidosis. A severe autonomic dysfunction was observed in only 4 cases. Isolated sympathetic damage was found in 4 cases, parasympathetic damage in 5 and combined (parasympathetic and sympathetic) damage in 5. (One patient showed parasympathetic damage but he was unable to complete the sympathetic tests). No alteration was observed in the controls. Thirty months following the autonomic function investigation, 14 patients were unchanged clinically, one was worse and 2 died because of other disease. In conclusion, our results indicate that at least in some patients with less severe damage, autonomic neuropathy does not seem to carry a poor prognosis with respect to that previously reported in the literature. Since autonomic damage was also observed in biopsy positive asymptomatic patients, we suggest that autonomic neuropathy may represent an early marker of systemic AL amyloidosis.

Original languageEnglish
Pages (from-to)167-172
Number of pages6
JournalAmyloid
Volume3
Issue number3
Publication statusPublished - 1996

Fingerprint

Amyloidosis
Monoclonal Gammopathy of Undetermined Significance
Blood Pressure
Primary amyloidosis
Amyloid
Respiration
Heart Rate
Fats
Biopsy

Keywords

  • AL amyloidosis
  • Autonomic neuropathy
  • Dysautonomia
  • Monoclonal gammopathy of undetermined significance
  • Plasma cell dyscrasia

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Gemmi, F., Miliani, A., Bergesio, F., Salvadori, M., & Merlini, G. (1996). Functional study of autonomic neuropathy in primary (AL) amyloidosis. Amyloid, 3(3), 167-172.

Functional study of autonomic neuropathy in primary (AL) amyloidosis. / Gemmi, Fabrizio; Miliani, Anna; Bergesio, Franco; Salvadori, Maurizio; Merlini, Giampaolo.

In: Amyloid, Vol. 3, No. 3, 1996, p. 167-172.

Research output: Contribution to journalArticle

Gemmi, F, Miliani, A, Bergesio, F, Salvadori, M & Merlini, G 1996, 'Functional study of autonomic neuropathy in primary (AL) amyloidosis', Amyloid, vol. 3, no. 3, pp. 167-172.
Gemmi F, Miliani A, Bergesio F, Salvadori M, Merlini G. Functional study of autonomic neuropathy in primary (AL) amyloidosis. Amyloid. 1996;3(3):167-172.
Gemmi, Fabrizio ; Miliani, Anna ; Bergesio, Franco ; Salvadori, Maurizio ; Merlini, Giampaolo. / Functional study of autonomic neuropathy in primary (AL) amyloidosis. In: Amyloid. 1996 ; Vol. 3, No. 3. pp. 167-172.
@article{2b2a818d9254498ebf0730947e7fe495,
title = "Functional study of autonomic neuropathy in primary (AL) amyloidosis",
abstract = "In order to evaluate autonomic function in primary amyloidosis (AL), five non invasive tests (Valsalva ratio, heart rate variation during deep breathing, 30/15 ratio, blood pressure response to standing and blood pressure response to sustained handgrip) were performed in 16 patients with positive fat tissue aspirates (FTA) for amyloid (11 females, 5 males, aged 48-85 years). Three of 16 were asymptomatic and without signs of organ involvement. Ten normal subjects and 10 patients with monoclonal gammopathy of undetermined significance (MGUS) of similar age were studied as controls. Abnormal autonomic function was found in 15 of the 16 patients with AL amyloidosis. A severe autonomic dysfunction was observed in only 4 cases. Isolated sympathetic damage was found in 4 cases, parasympathetic damage in 5 and combined (parasympathetic and sympathetic) damage in 5. (One patient showed parasympathetic damage but he was unable to complete the sympathetic tests). No alteration was observed in the controls. Thirty months following the autonomic function investigation, 14 patients were unchanged clinically, one was worse and 2 died because of other disease. In conclusion, our results indicate that at least in some patients with less severe damage, autonomic neuropathy does not seem to carry a poor prognosis with respect to that previously reported in the literature. Since autonomic damage was also observed in biopsy positive asymptomatic patients, we suggest that autonomic neuropathy may represent an early marker of systemic AL amyloidosis.",
keywords = "AL amyloidosis, Autonomic neuropathy, Dysautonomia, Monoclonal gammopathy of undetermined significance, Plasma cell dyscrasia",
author = "Fabrizio Gemmi and Anna Miliani and Franco Bergesio and Maurizio Salvadori and Giampaolo Merlini",
year = "1996",
language = "English",
volume = "3",
pages = "167--172",
journal = "Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis",
issn = "1350-6129",
publisher = "Taylor and Francis Ltd.",
number = "3",

}

TY - JOUR

T1 - Functional study of autonomic neuropathy in primary (AL) amyloidosis

AU - Gemmi, Fabrizio

AU - Miliani, Anna

AU - Bergesio, Franco

AU - Salvadori, Maurizio

AU - Merlini, Giampaolo

PY - 1996

Y1 - 1996

N2 - In order to evaluate autonomic function in primary amyloidosis (AL), five non invasive tests (Valsalva ratio, heart rate variation during deep breathing, 30/15 ratio, blood pressure response to standing and blood pressure response to sustained handgrip) were performed in 16 patients with positive fat tissue aspirates (FTA) for amyloid (11 females, 5 males, aged 48-85 years). Three of 16 were asymptomatic and without signs of organ involvement. Ten normal subjects and 10 patients with monoclonal gammopathy of undetermined significance (MGUS) of similar age were studied as controls. Abnormal autonomic function was found in 15 of the 16 patients with AL amyloidosis. A severe autonomic dysfunction was observed in only 4 cases. Isolated sympathetic damage was found in 4 cases, parasympathetic damage in 5 and combined (parasympathetic and sympathetic) damage in 5. (One patient showed parasympathetic damage but he was unable to complete the sympathetic tests). No alteration was observed in the controls. Thirty months following the autonomic function investigation, 14 patients were unchanged clinically, one was worse and 2 died because of other disease. In conclusion, our results indicate that at least in some patients with less severe damage, autonomic neuropathy does not seem to carry a poor prognosis with respect to that previously reported in the literature. Since autonomic damage was also observed in biopsy positive asymptomatic patients, we suggest that autonomic neuropathy may represent an early marker of systemic AL amyloidosis.

AB - In order to evaluate autonomic function in primary amyloidosis (AL), five non invasive tests (Valsalva ratio, heart rate variation during deep breathing, 30/15 ratio, blood pressure response to standing and blood pressure response to sustained handgrip) were performed in 16 patients with positive fat tissue aspirates (FTA) for amyloid (11 females, 5 males, aged 48-85 years). Three of 16 were asymptomatic and without signs of organ involvement. Ten normal subjects and 10 patients with monoclonal gammopathy of undetermined significance (MGUS) of similar age were studied as controls. Abnormal autonomic function was found in 15 of the 16 patients with AL amyloidosis. A severe autonomic dysfunction was observed in only 4 cases. Isolated sympathetic damage was found in 4 cases, parasympathetic damage in 5 and combined (parasympathetic and sympathetic) damage in 5. (One patient showed parasympathetic damage but he was unable to complete the sympathetic tests). No alteration was observed in the controls. Thirty months following the autonomic function investigation, 14 patients were unchanged clinically, one was worse and 2 died because of other disease. In conclusion, our results indicate that at least in some patients with less severe damage, autonomic neuropathy does not seem to carry a poor prognosis with respect to that previously reported in the literature. Since autonomic damage was also observed in biopsy positive asymptomatic patients, we suggest that autonomic neuropathy may represent an early marker of systemic AL amyloidosis.

KW - AL amyloidosis

KW - Autonomic neuropathy

KW - Dysautonomia

KW - Monoclonal gammopathy of undetermined significance

KW - Plasma cell dyscrasia

UR - http://www.scopus.com/inward/record.url?scp=0011979228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0011979228&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0011979228

VL - 3

SP - 167

EP - 172

JO - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

JF - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

SN - 1350-6129

IS - 3

ER -